Top compounds associated with response to TOR3A


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.003
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.1 0.003
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.1 0.003
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.095 0.004
mRNA ETP-46464 CTRPv2 pan-cancer AAC 0.13 0.004
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC 0.12 0.005
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.095 0.005
Download CSV